• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS ANTI-HBS II; HEPATITIS B TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS ANTI-HBS II; HEPATITIS B TEST Back to Search Results
Catalog Number 08498610190
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/07/2024
Event Type  malfunction  
Manufacturer Narrative
The analyzer serial number is (b)(6).The samples were requested for investigation.The investigation is ongoing.
 
Event Description
There was an allegation of false positive elecsys anti-hbs ii results for 1 patient on a cobas e 801 analytical unit.The hbsag result was 8.25 coi (positive).The anti-hbs result was 51 iu/l.The a-hbc result was 0.01 coi (positive) on (b)(6) 2024 the patient results were: the hbsag result was 7.75 coi (positive).The anti-hbs result was 40 iu/l.The a-hbc: result was 0.01 coi (positive).A competitor's method was used (attelica) and the results were: the hbsag result was positive.The a-hbs result was negative.The a-hbc result was positive.Numerical results for the competitor's method were not provided.
 
Manufacturer Narrative
Two samples were received for investigation on 28-mar-2024.The samples were tested on a cobas e 801 and a cobas pro with cir retention kits.Investigation results: sample 1: the anti-hbs ii result was 44.4 iu/l.The anti-hbc ii result was 0.00707 coi reactive.The hbsag ii result was 9.16 coi reactive.Sample 2: the anti-hbs ii result was 45.3 iu/l.The anti-hbc ii result was 0.00714 coi reactive.The hbsag ii result was 9.42 coi reactive.The positive anti-hbs ii result was reproduced during the investigation.Therefore, the positive anti-hbs ii result is assumed to be unspecific/false positive.A (lot independent) interference is most likely.Product labeling states: "individuals that have received blood component therapy, e.G.Whole blood, plasma, immune globulin administration, during the previous 3 to 6 months may have a false reactive anti-hbs result due to passive transfer of anti-hbs." the reagent performed within specification.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS ANTI-HBS II
Type of Device
HEPATITIS B TEST
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key19021420
MDR Text Key339136662
Report Number1823260-2024-01009
Device Sequence Number1
Product Code LOM
Combination Product (y/n)Y
Reporter Country CodeFR
PMA/PMN Number
P190034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/03/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/02/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number08498610190
Device Lot Number716600
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/22/2024
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-